Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

14.77

+0.47 (3.29%)

At close: Nov 4, 2026, 4:00 PM EST

14.78

+0.01 (0.07%)

After-hours: Nov 4, 2026, 7:59 PM EST

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	12,094	11,141	11,155	12,302	9,348	9,415
Market Cap Growth	8.08%	-0.13%	-9.32%	31.60%	-0.71%	-8.08%
Enterprise Value	12,086	11,018	11,097	11,669	8,972	9,322
Last Close Price	14.77	13.77	13.05	14.45	11.15	10.84

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	41.54	24.38	16.86	18.41	17.03	30.32
PS Ratio	3.52	3.11	2.93	3.67	3.12	3.33
PB Ratio	2.98	2.75	2.83	3.65	3.32	3.75
P/TBV Ratio	4.31	4.03	4.24	4.28	3.92	4.50
P/FCF Ratio	82.51	31.25	50.37	35.31	16.14	53.13
P/OCF Ratio	36.95	18.41	20.53	22.56	13.04	25.42

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	3.51	3.08	2.91	3.48	3.00	3.30
EV/EBITDA Ratio	23.27	15.16	10.80	12.31	11.16	14.82
EV/EBIT Ratio	38.55	20.98	13.17	14.89	13.79	19.70
EV/FCF Ratio	82.46	30.91	50.10	33.49	15.50	52.61

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.19	0.20	0.14	0.07	0.06	0.18
Debt / EBITDA Ratio	1.40	1.11	0.53	0.25	0.20	0.71
Debt / FCF Ratio	5.22	2.31	2.47	0.69	0.28	2.52
Net Debt / Equity Ratio	-0.01	-0.03	-0.03	-0.22	-0.21	-0.05
Net Debt / EBITDA Ratio	-0.08	-0.15	-0.13	-0.78	-0.73	-0.22
Net Debt / FCF Ratio	-0.29	-0.31	-0.59	-2.12	-1.02	-0.78
Asset Turnover	0.59	0.63	0.74	0.79	0.80	0.77
Inventory Turnover	2.12	2.15	2.01	2.06	2.14	2.09
Quick Ratio	1.15	1.13	1.16	1.72	1.58	1.24
Current Ratio	1.93	1.80	1.92	2.58	2.38	1.93
Return on Equity (ROE)	7.34%	11.83%	18.53%	21.77%	21.38%	12.96%
Return on Assets (ROA)	3.37%	5.74%	10.22%	11.51%	10.86%	8.04%
Return on Invested Capital (ROIC)	6.17%	10.96%	19.70%	25.19%	21.99%	15.03%
Return on Capital Employed (ROCE)	7.20%	12.00%	19.90%	22.40%	22.60%	18.10%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	2.41%	4.10%	5.93%	5.43%	5.87%	3.30%
FCF Yield	1.21%	3.20%	1.98%	2.83%	6.19%	1.88%
Dividend Yield	0.44%	0.64%	0.70%	0.65%	0.87%	0.70%
Payout Ratio	18.24%	15.54%	11.78%	11.94%	11.05%	17.59%
Buyback Yield / Dilution	0.05%	0.10%	-0.08%	-0.19%	-0.03%	-0.01%
Total Shareholder Return	0.48%	0.74%	0.62%	0.46%	0.84%	0.68%

SEC Filings: 10-K · 10-Q